TSHR-based chimeric antigen receptor T cell specifically deplete auto-reactive B lymphocytes for treatment of autoimmune thyroid disease
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110873 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Honghong Duan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of obstetrics and gynecology, The Second affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, China. Hauptthemen laut MEDLINE: Receptors, Thyrotropin, B-Lymphocytes, Receptors, Chimeric Antigen, Graves Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Education of Fujian Province, Science and Technology Projects of Fujian Province.
Abstract (Originalsprache)
Graves' disease (GD) is a prominent antibody-mediated autoimmune disorder characterized by stimulating antibodies (TRAb) that target the thyroid-stimulating hormone receptor (TSHR). Targeting and eliminating TRAb-producing B lymphocytes hold substantial therapeutic potential for GD. In this study, we engineered a novel chimeric antigen receptor T cell (CAR-T) therapy termed TSHR-CAR-T. This CAR-T construct incorporates the extracellular domain of the TSH receptor fused with the CD8 transmembrane and intracellular signal domain (4-1BB). TSHR-CAR-T cells demonstrated the ability to recognize and effectively eliminate TRAb-producing B lymphocytes both in vitro and in vivo. Leveraging this autoantigen-based chimeric receptor, our findings suggest that TSHR-CAR-T cells offer a promising and innovative immunotherapeutic approach for the treatment of antibody-mediated autoimmune diseases, including GD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of obstetrics and gynecology, The Second affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, China.
- Department of Endocrinology, The Second affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, China.
- Department of Endocrinology, The Second affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, China. Electronic address: huibinhuang@fjmu.edu.cn.
Förderung
- Department of Education of Fujian Province
- Science and Technology Projects of Fujian Province
Zitieren
APA
Duan, H., Jiang, Z., Chen, L., Bai, X., Cai, H., Yang, X., & Huang, H. (2023). TSHR-based chimeric antigen receptor T cell specifically deplete auto-reactive B lymphocytes for treatment of autoimmune thyroid disease. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110873
Vancouver
Duan H, Jiang Z, Chen L, Bai X, Cai H, Yang X, et al. TSHR-based chimeric antigen receptor T cell specifically deplete auto-reactive B lymphocytes for treatment of autoimmune thyroid disease. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110873
BibTeX
@article{Duan2023,
author = {Duan, Honghong and Jiang, Zhengrong and Chen, Lijun and Bai, Xuefeng and Cai, Huiyao and Yang, Xinna and Huang, Huibin},
title = {TSHR-based chimeric antigen receptor T cell specifically deplete auto-reactive B lymphocytes for treatment of autoimmune thyroid disease},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110873}
}
EUVIMED